Google DeepMind has introduced AlphaGenome, a new AI program designed to analyze the human genome. Following the success of AlphaFold2, which predicts protein structures, AlphaGenome focuses on DNA. It leverages extensive molecular data to forecast the effects of gene mutations, such as whether they will activate or deactivate a gene at inappropriate times. This capability is significant for understanding diseases like cancer. The announcement of AlphaGenome was made in the journal Nature. Researchers trained the AI on a comprehensive dataset, allowing it to make predictions about thousands of genes. Peter Koo, a computational biologist, praised AlphaGenome as a notable advancement in applying AI to genetic research. The implications of this technology could lead to better insights into genetic diseases and new therapeutic strategies.